Late results with bioprosthetic valves in the elderly

Journal of Cardiac Surgery

Volumn 14, Issue 4, 1999, Pages 252-256

  Helft, Gérard ^a,b,c   Tabone, Xavier ^a   Georges, Jean L ^a   Lomama, Eale ^b   Lepailleur, Claude ^a   Le Feuvre, Claude ^a   Ph Metzger, Jean ^a   Heulin, André ^a   Vacheron, André ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Centre Médical des Pins   (France)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGED; AORTA VALVE PROSTHESIS; ARTICLE; BIOPROSTHESIS; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROSTHESIS; REOPERATION; SURVIVAL TIME;

EID: 0033366617     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.1999.tb00989.x     Document Type: Article

References (24)

1. Bloomfield P, Wheatley DJ, Prescott RJ, et al: Twelve-year comparison of a Björk-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 1991;324:573-579.
2. Logeais Y, Langanay T, Corbineau H, et al: Aortic valve replacement in the elderly: Bioprosthesis or mechanical valve? Ann Thorac Surg 1998;66:S77-81.
3. Jamieson WE, Burr LH, Miyagishima RT, et al: Actuarial versus actual freedom from structural valve deterioration with the Carpentier-Edwards porcine bioprostheses. Can J Cardio 1999;15:973-978.
4. Jamieson WRE, Burr LH, Munro AL, et al: Cardiac valve replacement in the elderly: Clinical performances of biological prostheses. Ann Thorac Surg 1989;48:173-185.
5. Burr LH, Jamieson WR, Munro AI, et al: Porcine bioprostheses in the elderly: Clinical performance by age groups and valve positions. Ann Thorac Surg 1995;60:S264-269.
6. Pupello DF, Bessone LN, Hiro SP, et al: Bioprosthetic valve longevity in the elderly: An 18-year longitudinal study. Ann Thorac Surg 1995;60:S270-275.
7. Holper K, Wottke M, Lewe T, et al: Bioprosthetic and mechanical valves in the elderly: Benefits and risks. Ann Thorac Surg 1995;60:S443-446.
8. Helft G, Tabone X, Georges JL, et al: Bioprosthetic valve replacement in the elderly. Eur Heart J 1995;16:529-533.
9. Edmunds LH Jr, Clark RE, Cohn LH, et al: Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liason Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg 1996;62:932-935.
10. Hammermeister KE, Sethi GS, Henderson WG, et al for the Veterans Affairs Cooperative Study on Valvular Heart Disease: A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprostheses. N Engl J Med 1993;328:1289-1296.
11. Aortic valve selection in the elderly patient. Ann Thorac Surg 1988;46:270-277.
12. Antunes MJ: Valve replacement in the elderly. Is the mechanical valve a good alternative? J Thorac Cardiovasc Surg 1989;98:485-491.
13. Rooney S, Moreno de la Santa P, Lewis PA, et al: Sudden death in a large prosthetic valve series based on a single prosthesis: experience with the Medtronic Hall valve. J Heart Valve Dis 1994;3:5-9.
14. Nallet O, Roger V, Michel PL, et al: Pronostic des réinterventions pour dysfonction de bioprothèses. Arch Mal Coeur 1992;85:303-308.
15. Antunes MJ: Reoperations on cardiac valves. J Heart Valve Dis 1992;1:15-28.
16. Starr A, Grunkemeyer GL. The expected life of porcines valves. Ann Thorac Surg 1989;48:317-318.
17. Akins CW, Caroll DL, Buckley MJ, et al: Late results with Carpentier-Edwards porcine bioprosthesis. Circulation 1990;82 (Suppl. IV):65-74.
18. Jamieson WRE, Rosado LJ, Munro AI, et al: Carpentier-Edwards standard porcine bioprothesis: Primary tissue failure by age groups. Ann Thorac Surg 1988;46:155-62.
19. Legarra JJ, Llorens R, Catalan M, et al: Eighteen- year follow up after Hancock II bioprosthesis insertion. J Heart Valve Dis 1999;8:16-24.
20. Hutten BA, Lensing AW, Kraaijenhagen RA, et al: Safety of treatment with oral anticoagulants in the elderly. A systematic review. Drugs Aging 1999;14:303-312.
21. Saour JN, Sieck JO, Mamo LAR, et al: Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl N Med 1990;322:428-432.
22. Levine MN, Raskob G, Landefeld S, et al: Hemorrhagic complications of anticoagulant treatment. Chest 1998;114:S511-23.
23. Stein PD, Alpert JS, Dalen JE, et al: Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1998;114:S602-610.
24. Skudicky D, Essop MR, Wisenbaugh T, et al: Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude Medical prostheses. Am J Cardiol 1994;74:1137-41.